![](https://cdn.prod.website-files.com/61a5a1e4d7d0ec3b75092e9f/61a5a1e4d7d0ec22eb092f39_BTV%20Vertical%20Logo%20Black.png)
healthcare
![Reliq Health Technologies: Revolutionizing Community Healthcare with Innovative Virtual Care Solutions](https://cdn.prod.website-files.com/61a5a1e4d7d0ec3b75092e9f/61a5a1e4d7d0ecfdea092f16_Cat_bg_1.jpg)
The company is targeting the substantial $100 billion virtual care market and has already secured a client base that includes some of the largest and most well-regarded healthcare organizations nationwide.
![Defence Therapeutics: Revolutionizing Immune-Related Therapies with ACCUM Technology](https://cdn.prod.website-files.com/61a5a1e4d7d0ec3b75092e9f/61a5a1e4d7d0ecfdea092f16_Cat_bg_1.jpg)
Defence Therapeutics is a Canadian biotech company developing immune-related therapies using their proprietary ACCUM technology.
![Mulvihill ETFs - XLVE: U.S. Health Care Enhanced Yield ETF](https://cdn.prod.website-files.com/61a5a1e4d7d0ec3b75092e9f/61a5a1e4d7d0ecfdea092f16_Cat_bg_1.jpg)
Mulvihill's XLVE ETF offers exposure to large-cap US healthcare stocks with 25% leverage used for purchasing additional shares to write options, generating income from option premiums while maintaining close to "full" exposure to underlying portfolio stocks.
![Defence Therapeutics: Developing Immune-related Therapies for Cancer Treatment](https://cdn.prod.website-files.com/61a5a1e4d7d0ec3b75092e9f/61a5a1e4d7d0ecfdea092f16_Cat_bg_1.jpg)
Defence Therapeutics is a Canadian biotech company developing immune-related therapies for cancer treatment, including cancer vaccines, antibodies, and drug delivery vehicles.